A PHASE 3 STUDY TO DETERMINE THE EFFICACY AND SAFETY OFLENALIDOMIDE COMBINED WITH MELPHALAN AND PREDNISONE INPATIENTS = 65 YEARS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA(NDMM)